Login / Signup

A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma.

David A BondYing HuangBeth A ChristianSamantha M JaglowskiDon BensonLapo AlinariRobert A BaiocchiJonathon B CohenKristie A BlumKami J Maddocks
Published in: Leukemia & lymphoma (2022)
Keyphrases
  • hodgkin lymphoma
  • diffuse large b cell lymphoma
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • chronic lymphocytic leukemia